Update
$X4 Pharmaceuticals(XFOR.US$ Reuters· 2 mins ago
X4 Pharmaceuticals Announces $125 Million Capital Infusion From $105 Million Sale of Priority Review Voucher and $20 Million Drawdown From Existing Loan Facility
X4 Pharmaceuticals Announces $125 Million Capital Infusion From $105 Million Sale of Priority Review Voucher and $20 Million Drawdown From Existing Loan Facility
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
